US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 0.384
  • +0.009+2.43%
15min DelayClose May 28 16:00 ET
2.63MMarket Cap-738P/E (TTM)

Agile Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
49.91%5.72M
80.02%19.59M
-9.56%3.61M
121.92%6.66M
158.84%5.5M
116.52%3.81M
165.40%10.88M
163.94%4M
133.26%3M
79.41%2.13M
Operating revenue
49.91%5.72M
80.02%19.59M
-9.56%3.61M
121.92%6.66M
158.84%5.5M
116.52%3.81M
165.40%10.88M
163.94%4M
133.26%3M
79.41%2.13M
Cost of revenue
-16.13%1.68M
31.33%8.98M
32.55%2.19M
73.82%2.48M
3.41%2.31M
31.17%2M
-36.22%6.84M
-71.01%1.65M
-47.44%1.43M
94.85%2.23M
Gross profit
122.98%4.04M
162.23%10.62M
-39.27%1.42M
165.38%4.19M
3,143.81%3.2M
673.50%1.81M
161.18%4.05M
155.96%2.34M
210.74%1.58M
-362.50%-105K
Operating expense
-20.25%6.79M
-32.94%30.5M
-40.62%5.48M
-10.67%8.19M
-26.31%8.32M
-46.11%8.52M
-29.36%45.48M
-49.25%9.22M
-36.15%9.16M
-32.34%11.29M
Selling and administrative expenses
-18.79%6.3M
-33.05%28.27M
-38.88%5.42M
-10.69%7.48M
-27.00%7.62M
-46.70%7.76M
-27.37%42.23M
-46.23%8.87M
-34.35%8.38M
-34.06%10.44M
-Selling and marketing expense
-21.16%3.68M
-41.49%17.77M
-45.53%3.73M
-13.67%4.8M
-38.33%4.57M
-55.75%4.67M
-30.10%30.37M
-48.06%6.85M
-40.76%5.56M
-38.12%7.41M
-General and administrative expense
-15.20%2.62M
-11.42%10.51M
-16.36%1.69M
-4.80%2.68M
0.76%3.05M
-22.82%3.09M
-19.31%11.86M
-38.92%2.02M
-16.49%2.82M
-21.44%3.03M
Research and development costs
-35.12%495K
-31.60%2.23M
-84.66%54K
-10.53%705K
-17.87%703K
-39.30%763K
-47.92%3.25M
-79.02%352K
-50.53%788K
-0.70%856K
Operating profit
58.90%-2.76M
52.01%-19.88M
41.09%-4.05M
47.27%-4M
55.03%-5.13M
56.93%-6.71M
41.65%-41.43M
69.24%-6.88M
51.91%-7.59M
31.55%-11.4M
Net non-operating interest income expense
56.10%-162K
56.05%-1.34M
28.36%-288K
65.76%-328K
56.52%-357K
57.63%-369K
21.55%-3.05M
59.76%-402K
4.01%-958K
16.73%-821K
Non-operating interest income
-30.30%23K
-2.50%78K
-43.33%17K
-71.74%13K
650.00%15K
3,200.00%33K
220.00%80K
2,900.00%30K
4,500.00%46K
-71.43%2K
Non-operating interest expense
-53.98%185K
-54.68%1.42M
-29.40%305K
-66.04%341K
-54.80%372K
-53.90%402K
-20.01%3.13M
-56.80%432K
0.50%1M
-17.12%823K
Other net income (expense)
149.14%4.2M
-53.05%6.76M
-103.88%-130K
35.00%3.53M
-76.26%1.67M
21.89%1.69M
276.22%14.4M
3.35M
2.61M
7.05M
Gain on sale of security
149.14%4.2M
-73.51%6.76M
-103.88%-130K
-74.31%3.53M
-76.26%1.67M
21.89%1.69M
566.84%25.52M
--3.35M
--13.74M
--7.05M
Special income (charges)
----
--0
--0
--0
----
----
---11.12M
--0
---11.12M
----
-Gain on sale of property,plant,equipment
----
--0
--0
--0
----
----
---11.12M
--0
---11.12M
----
Income before tax
123.82%1.28M
51.92%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
64.21%-5.39M
57.66%-30.09M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
Income tax
0
0
0
0
0
0
-4.68M
0
0
0
Net income
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
Net income continuous Operations
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
Minority interest income
Net income attributable to the parent company
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
Basic earnings per share
104.74%0.28
88.59%-6.71
71.80%-1.41
96.63%-0.27
96.25%-2.15
96.45%-5.91
95.98%-58.79
98.75%-5
97.78%-8.01
85.68%-57.29
Diluted earnings per share
104.74%0.28
88.59%-6.71
71.80%-1.41
96.63%-0.27
96.25%-2.15
96.45%-5.91
95.98%-58.79
98.75%-5
97.78%-8.01
85.68%-57.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 49.91%5.72M80.02%19.59M-9.56%3.61M121.92%6.66M158.84%5.5M116.52%3.81M165.40%10.88M163.94%4M133.26%3M79.41%2.13M
Operating revenue 49.91%5.72M80.02%19.59M-9.56%3.61M121.92%6.66M158.84%5.5M116.52%3.81M165.40%10.88M163.94%4M133.26%3M79.41%2.13M
Cost of revenue -16.13%1.68M31.33%8.98M32.55%2.19M73.82%2.48M3.41%2.31M31.17%2M-36.22%6.84M-71.01%1.65M-47.44%1.43M94.85%2.23M
Gross profit 122.98%4.04M162.23%10.62M-39.27%1.42M165.38%4.19M3,143.81%3.2M673.50%1.81M161.18%4.05M155.96%2.34M210.74%1.58M-362.50%-105K
Operating expense -20.25%6.79M-32.94%30.5M-40.62%5.48M-10.67%8.19M-26.31%8.32M-46.11%8.52M-29.36%45.48M-49.25%9.22M-36.15%9.16M-32.34%11.29M
Selling and administrative expenses -18.79%6.3M-33.05%28.27M-38.88%5.42M-10.69%7.48M-27.00%7.62M-46.70%7.76M-27.37%42.23M-46.23%8.87M-34.35%8.38M-34.06%10.44M
-Selling and marketing expense -21.16%3.68M-41.49%17.77M-45.53%3.73M-13.67%4.8M-38.33%4.57M-55.75%4.67M-30.10%30.37M-48.06%6.85M-40.76%5.56M-38.12%7.41M
-General and administrative expense -15.20%2.62M-11.42%10.51M-16.36%1.69M-4.80%2.68M0.76%3.05M-22.82%3.09M-19.31%11.86M-38.92%2.02M-16.49%2.82M-21.44%3.03M
Research and development costs -35.12%495K-31.60%2.23M-84.66%54K-10.53%705K-17.87%703K-39.30%763K-47.92%3.25M-79.02%352K-50.53%788K-0.70%856K
Operating profit 58.90%-2.76M52.01%-19.88M41.09%-4.05M47.27%-4M55.03%-5.13M56.93%-6.71M41.65%-41.43M69.24%-6.88M51.91%-7.59M31.55%-11.4M
Net non-operating interest income expense 56.10%-162K56.05%-1.34M28.36%-288K65.76%-328K56.52%-357K57.63%-369K21.55%-3.05M59.76%-402K4.01%-958K16.73%-821K
Non-operating interest income -30.30%23K-2.50%78K-43.33%17K-71.74%13K650.00%15K3,200.00%33K220.00%80K2,900.00%30K4,500.00%46K-71.43%2K
Non-operating interest expense -53.98%185K-54.68%1.42M-29.40%305K-66.04%341K-54.80%372K-53.90%402K-20.01%3.13M-56.80%432K0.50%1M-17.12%823K
Other net income (expense) 149.14%4.2M-53.05%6.76M-103.88%-130K35.00%3.53M-76.26%1.67M21.89%1.69M276.22%14.4M3.35M2.61M7.05M
Gain on sale of security 149.14%4.2M-73.51%6.76M-103.88%-130K-74.31%3.53M-76.26%1.67M21.89%1.69M566.84%25.52M--3.35M--13.74M--7.05M
Special income (charges) ------0--0--0-----------11.12M--0---11.12M----
-Gain on sale of property,plant,equipment ------0--0--0-----------11.12M--0---11.12M----
Income before tax 123.82%1.28M51.92%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M64.21%-5.39M57.66%-30.09M79.87%-3.93M64.64%-5.93M70.70%-5.17M
Income tax 000000-4.68M000
Net income 123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M
Net income continuous Operations 123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M
Minority interest income
Net income attributable to the parent company 123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 123.82%1.28M43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M
Basic earnings per share 104.74%0.2888.59%-6.7171.80%-1.4196.63%-0.2796.25%-2.1596.45%-5.9195.98%-58.7998.75%-597.78%-8.0185.68%-57.29
Diluted earnings per share 104.74%0.2888.59%-6.7171.80%-1.4196.63%-0.2796.25%-2.1596.45%-5.9195.98%-58.7998.75%-597.78%-8.0185.68%-57.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg